232 related articles for article (PubMed ID: 25059438)
1. The influence of vascular risk factors on cognitive decline in patients with Alzheimer's disease.
Blom K; Vaartjes I; Peters SA; Koek HL
Maturitas; 2014 Sep; 79(1):96-9. PubMed ID: 25059438
[TBL] [Abstract][Full Text] [Related]
2. Summative Effects of Vascular Risk Factors on the Progression of Alzheimer Disease.
Lee WJ; Liao YC; Wang YF; Lin YS; Wang SJ; Fuh JL
J Am Geriatr Soc; 2020 Jan; 68(1):129-136. PubMed ID: 31587263
[TBL] [Abstract][Full Text] [Related]
3. Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
Bergland AK; Dalen I; Larsen AI; Aarsland D; Soennesyn H
J Alzheimers Dis; 2017; 56(2):575-584. PubMed ID: 28035932
[TBL] [Abstract][Full Text] [Related]
4. The influence of vascular risk factors on cognitive function in early Parkinson's disease.
Doiron M; Langlois M; Dupré N; Simard M
Int J Geriatr Psychiatry; 2018 Feb; 33(2):288-297. PubMed ID: 28509343
[TBL] [Abstract][Full Text] [Related]
5. Cognitive decline precedes late-life longitudinal changes in vascular risk factors.
van Vliet P; Westendorp RG; van Heemst D; de Craen AJ; Oleksik AM
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):1028-32. PubMed ID: 20543187
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure variability in Alzheimer's disease and frontotemporal dementia: the effect on the rate of cognitive decline.
Lattanzi S; Luzzi S; Provinciali L; Silvestrini M
J Alzheimers Dis; 2015; 45(2):387-94. PubMed ID: 25790932
[TBL] [Abstract][Full Text] [Related]
7. Serum leptin is not altered nor related to cognitive decline in Alzheimer's disease.
Teunissen CE; van der Flier WM; Scheltens P; Duits A; Wijnstok N; Nijpels G; Dekker JM; Blankenstein RM; Heijboer AC
J Alzheimers Dis; 2015; 44(3):809-13. PubMed ID: 25352450
[TBL] [Abstract][Full Text] [Related]
8. Reduced vascular risk factors in Parkinson's disease dementia and dementia with Lewy bodies compared to Alzheimer's disease.
Chan PC; Wei CY; Hung GU; Chiu PY
Brain Behav; 2018 Mar; 8(3):e00916. PubMed ID: 29541536
[TBL] [Abstract][Full Text] [Related]
9. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol profiles and incident cognitive decline among older adults: the Shanghai Aging Study.
Ding D; Zhou F; Cao Y; Liang X; Wu W; Xiao Z; Zhao Q; Deng W
Age Ageing; 2021 Feb; 50(2):472-479. PubMed ID: 32766741
[TBL] [Abstract][Full Text] [Related]
11. Effects of APOE haplotypes and measures of cardiovascular risk over gender-dependent cognitive and functional changes in one year in Alzheimer's disease.
de Oliveira FF; Pereira FV; Pivi GAK; Smith MC; Bertolucci PHF
Int J Neurosci; 2018 May; 128(5):472-476. PubMed ID: 29064737
[TBL] [Abstract][Full Text] [Related]
12. Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study.
Beeri MS; Lin HM; Sano M; Ravona-Springer R; Liu X; Bendlin BB; Gleason CE; Guerrero-Berroa E; Soleimani L; Launer LJ; Ehrenberg S; Lache O; Seligman YK; Levy AP
JAMA Netw Open; 2018 Nov; 1(7):e184458. PubMed ID: 30646354
[TBL] [Abstract][Full Text] [Related]
13. Cortical atrophy mediates the accumulating effects of vascular risk factors on cognitive decline in the Alzheimer's disease spectrum.
Wang Q; He C; Zhu Y; Zhang Q; Zhang Z; Xie C
Aging (Albany NY); 2020 Jul; 12(14):15058-15076. PubMed ID: 32726298
[TBL] [Abstract][Full Text] [Related]
14. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
[TBL] [Abstract][Full Text] [Related]
15. [Isolated systolic hypertension and cognitive function in the aged. Experience of the Syst-Eur study].
Seux ML; Thijs L; Forette F
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1169-72. PubMed ID: 9404430
[TBL] [Abstract][Full Text] [Related]
16. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia.
Corey-Bloom J; Galasko D; Hofstetter CR; Jackson JE; Thal LJ
J Am Geriatr Soc; 1993 Jan; 41(1):31-7. PubMed ID: 8418119
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort.
Kramberger MG; Auestad B; Garcia-Ptacek S; Abdelnour C; Olmo JG; Walker Z; Lemstra AW; Londos E; Blanc F; Bonanni L; McKeith I; Winblad B; de Jong FJ; Nobili F; Stefanova E; Petrova M; Falup-Pecurariu C; Rektorova I; Bostantjopoulou S; Biundo R; Weintraub D; Aarsland D;
J Alzheimers Dis; 2017; 57(3):787-795. PubMed ID: 28304294
[TBL] [Abstract][Full Text] [Related]
18. Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study.
Laske C; Sopova K; Hoffmann N; Stransky E; Hagen K; Fallgatter AJ; Stellos K; Leyhe T
J Alzheimers Dis; 2011; 26(1):39-45. PubMed ID: 21593573
[TBL] [Abstract][Full Text] [Related]
19. Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease.
Masse I; Bordet R; Deplanque D; Al Khedr A; Richard F; Libersa C; Pasquier F
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1624-9. PubMed ID: 16291883
[TBL] [Abstract][Full Text] [Related]
20. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs.
Mossello E; Pieraccioli M; Nesti N; Bulgaresi M; Lorenzi C; Caleri V; Tonon E; Cavallini MC; Baroncini C; Di Bari M; Baldasseroni S; Cantini C; Biagini CA; Marchionni N; Ungar A
JAMA Intern Med; 2015 Apr; 175(4):578-85. PubMed ID: 25730775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
